Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vaccination Against High Risk Breast Cancer With Autologous Tumor-Derived Heat Shock Protein 70-Peptide Complexes (HSP70)

NCT00027131 is registered in ClinicalTrials.gov with UConn Health as lead sponsor.

NCT NCT00027131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00027131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vaccination Against High Risk Breast Cancer With Autologous Tumor-Derived Heat Shock Protein 70-Peptide Complexes (HSP70)
Lead sponsor
UConn Health
Phase
Phase 1/2
Overall status
Terminated
Start date
December 31, 2000
Completion date
October 31, 2002
Enrollment
15
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms